Is anti-IL-31 receptor antibody shown to be a potential therapeutic option for treating itch and dermatitis in mice?
Anti-IL-31 receptor α is a potential novel therapeutic approach for escaping from the itch-scratch cycle and also a treatment for dermatitis in AD.
Cholelithiasis is a risk factor for colorectal adenoma.